US 9556200
Tricyclic compound
granted A61PA61P1/04A61P1/12
Quick answer
US patent 9556200 (Tricyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61P, A61P1/04, A61P1/12, A61P1/16, A61P11/00